Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated | Psychological Medicine | Cambridge Core (original) (raw)

References

Antshel, KM, Fremont, W, Roizen, NJ, Shprintzen, R, Higgins, AM, Dhamoon, A, Kates, WR (2006). ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 45, 596–603.Google Scholar

Antshel, KM, Shprintzen, R, Fremont, W, Higgins, AM, Faraone, SV, Kates, WR (2010). Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 49, 333–344.Google Scholar

Bassett, AS, Chow, EW (2008). Schizophrenia and 22q11.2 deletion syndrome. Current Psychiatry Reports 10, 148–157.Google Scholar

Bassett, AS, Chow, EW, AbdelMalik, P, Gheorghiu, M, Husted, J, Weksberg, R (2003). The schizophrenia phenotype in 22q11 deletion syndrome. American Journal of Psychiatry 160, 1580–1586.Google Scholar

Bassett, AS, McDonald-McGinn, DM, Devriendt, K, Digilio, MC, Goldenberg, P, Habel, A, Marino, B, Oskarsdottir, S, Philip, N, Sullivan, K, Swillen, A, Vorstman, J; International 22q11.2 Deletion Syndrome Consortium (2011). Practical guidelines for managing patients with 22q11.2 deletion syndrome. Journal of Pediatrics 159, 332–9.e1.Google Scholar

Botto, LD, May, K, Fernhoff, PM, Correa, A, Coleman, K, Rasmussen, SA, Merritt, RK, O'Leary, LA, Wong, L-Y, Elixson, EM (2003). A population-based study of the 22q11. 2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112, 101–107.Google Scholar

Dreessen, L, Arntz, A (1998). Short-interval test-retest interrater reliability of the Structured Clinical Interview for DSM-III-R personality disorders (SCID-II) in outpatients. Journal of Personality Disorders 12, 138–148.Google Scholar

Fabbro, A, Rizzi, E, Schneider, M, Debbane, M, Eliez, S (2012). Depression and anxiety disorders in children and adolescents with velo-cardio-facial syndrome (VCFS). European Child and Adolescent Psychiatry 21, 379–385.Google Scholar

First, MB, Gibbon, M (2004). The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). In Comprehensive Handbook of Psychological Assessment. Vol. 2, Personality Assessment (ed. Hilsenroth, M. J. and Segal, D. L.), pp. 134–143. John Wiley & Sons, Inc.: Hoboken, NJ.Google Scholar

Goldenberg, PC, Calkins, ME, Richard, J, McDonald-McGinn, D, Zackai, E, Mitra, N, Emanuel, B, Devoto, M, Borgmann-Winter, K, Kohler, C, Conroy, CG, Gur, RC, Gur, RE (2012). Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 159B, 87–93.Google Scholar

Gothelf, D, Feinstein, C, Thompson, T, Gu, E, Penniman, L, Van Stone, E, Kwon, H, Eliez, S, Reiss, AL (2007). Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. American Journal of Psychiatry 164, 663–669.Google Scholar

Green, T, Gothelf, D, Glaser, B, Debbane, M, Frisch, A, Kotler, M, Weizman, A, Eliez, S (2009). Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 48, 1060–1068.Google Scholar

Gur, RE, Kohler, C, Turetsky, BI, Siegel, SJ, Kanes, SJ, Bilker, WB, Brennan, AR, Gur, RC (2004). A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biological Psychiatry 55, 512–517.Google Scholar

Hafner, H, an der Heiden, W, Behrens, S, Gattaz, WF, Hambrecht, M, Loffler, W, Maurer, K, Munk-Jorgensen, P, Nowotny, B, Riecher-Rossler, A, Stein, A (1998). Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophrenia Bulletin 24, 99–113.Google Scholar

Jawad, AF, McDonald-McGinn, DM, Zackai, E, Sullivan, KE (2001). Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Journal of Pediatrics 139, 715–723.Google Scholar

Jolin, EM, Weller, RA, Jessani, NR, Zackai, EH, McDonald-McGinn, DM, Weller, EB (2009). Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 deletion syndrome. Journal of Affective Disorders 119, 177–180.Google Scholar

Jolin, EM, Weller, RA, Weller, EB (2012). Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome. Journal of Affective Disorders 136, 222–228.Google Scholar

Kaufman, J, Birmaher, B, Brent, D, Rao, U, Flynn, C, Moreci, P, Williamson, D, Ryan, N (1997). Schedule for Affective Disorders and Schizophrenia for School-Age Children – Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry 36, 980–988.Google Scholar

McDonald-McGinn, DM, Minugh-Purvis, N, Kirschner, RE, Jawad, A, Tonnesen, MK, Catanzaro, JR, Goldmuntz, E, Driscoll, D, Larossa, D, Emanuel, BS, Zackai, EH (2005). The 22q11.2 deletion in African-American patients: an underdiagnosed population? American Journal of Medical Genetics . Part A 134, 242–246.Google Scholar

McDonald-McGinn, DM, Tonnesen, MK, Laufer-Cahana, A, Finucane, B, Driscoll, DA, Emanuel, BS, Zackai, EH (2001). Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genetics in Medicine 3, 23–29.Google Scholar

Merikangas, KR, He, J-P, Rapoport, J, Vitiello, B, Olfson, M (2013). Medication use in US youth with mental disorders. JAMA Pediatrics 167, 141–148.Google Scholar

Merikangas, KR, He, MJ-P, Burstein, M, Swanson, MSA, Avenevoli, S, Cui, ML, Benjet, C, Georgiades, K, Swendsen, J (2010). Lifetime prevalence of mental disorders in US adolescents: results from the National Comorbidity Study – Adolescent Supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry 49, 980–989.Google Scholar

Michaelovsky, E, Frisch, A, Carmel, M, Patya, M, Zarchi, O, Green, T, Basel-Vanagaite, L, Weizman, A, Gothelf, D (2012). Genotype-phenotype correlation in 22q11.2 deletion syndrome. BMC Medical Genetics 13, 122.Google Scholar

Miller, TJ, McGlashan, TH, Rosen, JL, Cadenhead, K, Cannon, T, Ventura, J, McFarlane, W, Perkins, DO, Pearlson, GD, Woods, SW (2003). Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 29, 703–715.Google Scholar

Murphy, KC, Jones, LA, Owen, MJ (1999). High rates of schizophrenia in adults with velo-cardio-facial syndrome. Archives of General Psychiatry 56, 940–945.Google Scholar

Niklasson, L, Rasmussen, P, Oskarsdóttir, S, Gillberg, C (2009). Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Research in Developmental Disabilities 30, 763–773.Google Scholar

Schreiner, MJ, Lazaro, MT, Jalbrzikowski, M, Bearden, CE (2013). Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome. Neuropharmacology 68, 157–173.Google Scholar

Shapiro, DI, Cubells, JF, Ousley, OY, Rockers, K, Walker, EF (2011). Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder. Schizophrenia Research 129, 20–28.Google Scholar

Stoddard, J, Niendam, T, Hendren, R, Carter, C, Simon, TJ (2010). Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophrenia Research 118, 118–121.Google Scholar

Veerapandiyan, A, Abdul-Rahman, OA, Adam, MP, Lyons, MJ, Manning, M, Coleman, K, Kobrynski, L, Taneja, D, Schoch, K, Zimmerman, HH, Shashi, V (2011). Chromosome 22q11.2 deletion syndrome in African-American patients: a diagnostic challenge. American Journal of Medical Genetics. Part A 155A, 2186–2195.Google Scholar

Vorstman, JA, Morcus, ME, Duijff, SN, Klaassen, PW, Heineman-de Boer, JA, Beemer, FA, Swaab, H, Kahn, RS, van Engeland, H (2006). The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. Journal of the American Academy of Child and Adolescent Psychiatry 45, 1104–1113.Google Scholar

Wapner, RJ, Martin, CL, Levy, B, Ballif, BC, Eng, CM, Zachary, JM, Savage, M, Platt, LD, Saltzman, D, Grobman, WA, Klugman, S, Scholl, T, Simpson, JL, McCall, K, Aggarwal, VS, Bunke, B, Nahum, O, Patel, A, Lamb, AN, Thom, EA, Beaudet, AL, Ledbetter, DH, Shaffer, LG, Jackson, L (2012). Chromosomal microarray versus karyotyping for prenatal diagnosis. New England Journal of Medicine 367, 2175–2184.Google Scholar

Wilkinson, GS, Robertson, GJ (2006). Wide Range Achievement Test, Fourth Edition (WRAT4). Psychological Assessment Resources: Lutz, FL.Google Scholar